Literature DB >> 23254485

Treatment of refractory exposure keratitis with modified medial tarsorrhaphy using tarsoconjunctival flap.

Sun Young Jang1, Jin Sook Yoon.   

Abstract

BACKGROUND: This study reports the surgical technique of modified medial tarsorrhaphy using tarsoconjunctival advancement flap for treatment of exposure keratitis secondary to incomplete lid closure combined with ocular dysmotility or decreased corneal sensation.
METHODS: Three patients suffered from intractable exposure keratitis due to incomplete lid closure with ocular motility limitation or decreased corneal sensation, even after the lateral tightening procedure. Because they did not want a cosmetically unacceptable appearance by permanent tarsorrhaphy, modified medial tarsorrhaphy using tarsoconjunctival advancement flap was performed. Clinical manifestation and surgical outcome were investigated through retrospective chart review.
RESULTS: The minimum follow-up period was 10 months. All patients showed successful surgical results. Ocular symptoms were satisfactorily treated, corneal re-epithelialization was achieved and maintained during the follow-up period, lagophthalmos improved, and all patients were satisfied with their appearance.
CONCLUSIONS: We describe modified medial tarsorrhaphy with tarsoconjunctival advancement flap which was effective in treatment of severe exposure keratitis with incomplete lid closure in patients who elected not to have cosmetically problematic, permanent corrective surgery.

Entities:  

Mesh:

Year:  2012        PMID: 23254485     DOI: 10.1007/s00417-012-2238-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  Eyelid reanimation for the treatment of paralytic lagophthalmos: historical perspectives and current applications of the gold weight implant.

Authors:  D J Townsend
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1992       Impact factor: 1.746

2.  Müllerectomy for upper eyelid retraction and lagophthalmos due to facial nerve palsy.

Authors:  Adam S Hassan; Bartley R Frueh; Victor M Elner
Journal:  Arch Ophthalmol       Date:  2005-09

3.  Management of exposure keratopathy associated with severe craniofacial trauma.

Authors:  Zoë R Williams; James V Aquavella
Journal:  J Cataract Refract Surg       Date:  2007-09       Impact factor: 3.351

4.  A useful augmented lateral tarsal strip tarsorrhaphy for paralytic ectropion.

Authors:  Lydia Chang; Jane Olver
Journal:  Ophthalmology       Date:  2005-12-15       Impact factor: 12.079

5.  Ophthalmic management of the facial palsy patient.

Authors:  Philip L Custer
Journal:  Semin Plast Surg       Date:  2004-02       Impact factor: 2.314

6.  Surgical technique: modified lateral tarsorrhaphy.

Authors:  Don J de Silva; Yashin D Ramkissoon; Andre R Ismail; Michèle Beaconsfield
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2011 May-Jun       Impact factor: 1.746

7.  Complications of gold weight eyelid implants for treatment of fifth and seventh nerve paralysis.

Authors:  E A Dinces; J A Mauriello; J A Kwartler; M Franklin
Journal:  Laryngoscope       Date:  1997-12       Impact factor: 3.325

8.  Outcomes of periocular reconstruction for facial nerve paralysis in cancer patients.

Authors:  Dominick Golio; Sheri De Martelaere; James Anderson; Bita Esmaeli
Journal:  Plast Reconstr Surg       Date:  2007-04-01       Impact factor: 4.730

9.  Palpebral spring in the management of lagophthalmos and exposure keratopathy secondary to facial nerve palsy.

Authors:  Hakan Demirci; Bartley R Frueh
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2009 Jul-Aug       Impact factor: 1.746

10.  The use of N-butyl cyanoacrylate (indermil) in lateral tarsorrhaphy.

Authors:  Li Wern Voon; Chung Nen Chua; Richard Hanson
Journal:  Arch Ophthalmol       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.